| Serial Number | 90089929 |
| Word Mark | COVID-SEROINDEX |
| Filing Date | Monday, August 3, 2020 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, April 3, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 5, 2022 |
| Goods and Services | Diagnostic agents, preparations and substances for medical or veterinary purposes; Medical diagnostic reagents and assays for testing and analysis of blood, bodily fluids, biological and cellular samples and specimens; Reagents for medical use; Clinical medical reagents; Diagnostic assays, reagents, media, solutions and buffers for medical use; Diagnostic agents for carrying out serologic tests for medical purposes; Diagnostic reagents for serologic tests of infections for medical purposes; Diagnostic agents, preparations, substances and diagnostic test kits used for detecting antibodies, enzymes, antigens, diseases, viruses and infections for medical purposes; Test kits consisting of medical diagnostic reagents, assays, solutions and buffers for testing in the field of the prevention and treatment of infections, viruses, disorders and diseases; Diagnostic kits comprised of medical diagnostic reagents and assays for testing and analysis of blood, bodily fluids, biological and cellular samples and specimens for use in infection, virus and disease detection, namely, infectious, viral, communicable, blood-borne pathogen, vector-borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Diagnostic preparations for medical purposes for detecting the presence of infectious, viral, communicable, blood-borne pathogen, vector-borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Medicated, therapeutic and pharmaceutical preparations and substances for the prevention and treatment of SARS-CoV-2, COVID-19, and infectious, viral, communicable, blood-borne pathogen, vector-borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Specimen collection kits for use in medical and clinical testing for the presence of antibodies in blood, biological fluids, bodily fluids, biological and cellular samples and specimens and tissue comprised primarily of assays, reagents, media, solutions, buffers, antibodies, antigens, control materials, membranes, plasma, diagnostic chemicals, calibrators, swabs for medical purposes, plates, vessels, tubes, pipettes, trays, panels, slides, cards and bottles; all the foregoing related to the detection, diagnosis, testing, prevention and/or treatment of SARS-CoV-2, COVID-19 and antibodies, antigens, diseases, illnesses, viruses, disorders and/or infections related to SARS-CoV-2 or COVID-19 |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, September 1, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Kantaro Biosciences LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | New York, NY 10036 |
| Party Name | Kantaro Biosciences LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | New York, NY 10036 |
| Event Date | Event Description |
| Monday, April 3, 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, April 3, 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, August 30, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, July 5, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 5, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, June 15, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 31, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, May 31, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, May 31, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, May 31, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, May 31, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Sunday, November 14, 2021 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Sunday, November 14, 2021 | FINAL REFUSAL E-MAILED |
| Sunday, November 14, 2021 | FINAL REFUSAL WRITTEN |
| Friday, August 27, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, August 26, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, August 26, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, March 20, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Saturday, March 20, 2021 | NON-FINAL ACTION E-MAILED |
| Saturday, March 20, 2021 | NON-FINAL ACTION WRITTEN |
| Friday, February 26, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, February 26, 2021 | NON-FINAL ACTION E-MAILED |
| Friday, February 26, 2021 | NON-FINAL ACTION WRITTEN |
| Wednesday, February 10, 2021 | ASSIGNED TO EXAMINER |
| Tuesday, September 1, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, August 6, 2020 | NEW APPLICATION ENTERED |